Report Descriptions:

The Global Companion Animal Diagnostics Market was estimated at USD 6.95 billion in 2025 and is projected to reach USD 18.1 billion by 2035, growing at a robust CAGR of 10.05% during the forecast period from 2026 to 2035. The Companion Animal Diagnostics market report provides a comprehensive industry assessment, analyzing economic conditions, technological advancements, regulatory frameworks, and evolving consumer behavior to deliver a clear view of future growth potential.

With 2025 as the base year, the Companion Animal Diagnostics market is witnessing steady expansion driven by innovation, rising consumer demand, and rapid technological progress. Companies are increasingly refining their go-to-market (GTM) strategies to capture emerging opportunities and respond to shifting market dynamics.

Looking ahead to 2035, the market is expected to sustain its growth momentum, supported by continuous R&D investments, strategic partnerships, and mergers and acquisitions. Businesses that prioritize innovation, agile GTM strategies, and alignment with consumer needs are likely to achieve long-term success. The report delivers detailed insights into key drivers, restraints, opportunities, and challenges across segments, regions, and countries, supported by qualitative and quantitative analysis covering the period from 2017 to 2035.

Historical Analysis (2017 - 2024): Reviews past market trends, performance metrics, and growth patterns to identify factors shaping current and future market behavior.

Forecast and Projections (2026 - 2035): Provides forward-looking market estimates, highlighting growth opportunities, emerging trends, and regional developments.

Compound Annual Growth Rate (CAGR): Presents a clear CAGR calculation for 2026 - 2035, enabling stakeholders to evaluate market growth potential over the forecast period.

Companion Animal Diagnostics Market

Companion Animal Diagnostics Market

The companion animal diagnostics market comprises diagnostic instruments, consumables, reagents, software, and services used to detect, monitor, and manage diseases in companion animals such as dogs, cats, horses, and exotic pets. Diagnostic modalities span clinical chemistry, hematology, immunodiagnostics, molecular diagnostics (PCR, NGS), urinalysis, imaging (X-ray, ultrasound, CT, MRI), and point-of-care (POC) testing.

This market is emphasized on the total revenue generated by manufacturers and diagnostic service providers supplying veterinary clinics, animal hospitals, reference laboratories, and research institutions. As pets increasingly receive human-equivalent healthcare, diagnostics have become a core pillar of modern veterinary medicinesupporting early disease detection, chronic disease management, preventive screening, and personalized treatment pathways.

What are the drivers of companion animal diagnostics market

The market is driven by a powerful combination of demographic, technological, and economic shifts within global pet healthcare.

• Global pet ownership exceeds 1 billion animals, with dogs and cats accounting for the majorityfueling sustained demand for routine and advanced diagnostics.

• Pet humanization trends have led owners to spend 23 more on veterinary care than a decade ago, particularly for diagnostics and preventive screening.

• The prevalence of chronic diseases in pets is rising sharply1 in 4 dogs will develop cancer, while diabetes, kidney disease, and arthritis are increasingly diagnosed in aging pets.

• Technological advances in molecular diagnostics, AI-assisted imaging, and in-clinic analyzers have reduced turnaround times from days to minutes or hours, accelerating adoption.

• Pet insurance penetration is growing at 1215% CAGR in developed markets, lowering out-of-pocket diagnostic costs and encouraging comprehensive testing.

What are the challenges and restraining factors of companion animal diagnostics market

Despite strong growth fundamentals, structural and economic barriers persist.

• Advanced diagnostic equipment such as MRI or CT scanners can cost USD 500,0002 million, limiting adoption to large hospitals and specialty clinics.

• A global shortage of trained veterinarians and diagnostic specialists leads to underutilization of available diagnostic technologies, especially in rural and emerging markets.

• Regulatory approval processes from agencies such as FDA-CVM and USDA increase development timelines and compliance costs, slowing innovation cycles.

• In many regions, less than 1015% of pets are insured, leaving owners to pay diagnostic costs out of pocket and limiting test uptake.

What are the regional trends of companion animal diagnostics market

North America: The largest and most advanced market, driven by high pet ownership, strong insurance coverage, and rapid adoption of AI-enabled and point-of-care diagnostics. IDEXX and Zoetis dominate with continuous innovation.

Europe: Growth is supported by preventive care awareness, robust animal welfare regulations, and expanding molecular and genetic testingespecially in Germany, the UK, and France.

Asia Pacific: The fastest-growing region, with pet ownership rising at double-digit rates in China and India. Increased investment in veterinary infrastructure and affordable diagnostics is expanding access.

Latin America: Steady growth led by Brazil and Mexico, where clinics are upgrading to biochemistry analyzers, imaging tools, and infectious disease screening platforms.

Middle East & Africa: An emerging market driven by premium veterinary services in GCC countries and growing demand for mobile, AI-enabled, and molecular diagnostics.

Country-Wise Outlook:

United States:

The U.S. accounts for the largest share of global companion animal diagnostics revenue. Approximately 70% of U.S. households (87 million homes) own at least one pet. Chronic disease incidence and preventive wellness programs are driving widespread adoption of point-of-care analyzers, PCR testing, and AI-driven imaging. Companies like IDEXX and Zoetis continue to expand in-clinic diagnostics, with cancer screening emerging as a high-growth segment.

Germany:

Germanys market is shaped by preventive healthcare culture and rising pet insurance coverage. Dog and cat ownership increased from 40% to 46% of households between 2017 and 2024, significantly boosting routine diagnostic demand. Clinics increasingly adopt molecular diagnostics, wellness panels, and digital health tools, reinforcing Germanys role as a leading EU diagnostics market.

Japan:

Japans diagnostics market is driven by aging pets and a deep emotional bond between owners and animals. With nearly 19 million dogs and cats, pets outnumber children under 15. High adoption of AI-enabled health monitoring apps and precision diagnostics supports early disease detection and longevity-focused care.

Competitive Analysis:

The companion animal diagnostics market is highly competitive, with differentiation driven by technology, speed, accuracy, and ecosystem integration. Market leaders invest heavily in molecular diagnostics, AI-assisted imaging, and cloud-based data platforms.

Point-of-care diagnostics are a major battleground, as clinics demand fast results, minimal sample volumes, and ease of use. Companies bundling analyzers with consumables, software, and decision-support tools gain long-term customer loyalty.

Price sensitivity remains important in emerging markets, favoring companies offering cost-effective multi-analyte panels and modular diagnostic systems. Regional players compete by tailoring solutions to local disease profiles and breed-specific needs.

Service-based differentiation is increasing. Leading firms now offer digital records, tele-diagnostics, AI interpretation, and remote monitoringtransforming diagnostics into a recurring, data-driven service model.

Key players include IDEXX Laboratories, Zoetis Inc., Heska Corporation, Thermo Fisher Scientific Inc., Virbac, Neogen Corporation, BioNote Inc., Randox Laboratories, Abaxis (Zoetis), Mars Petcare (Antech Diagnostics), bioMrieux SA, Scil Animal Care Company GmbH, Fujifilm Corporation, QIAGEN N.V., and other players.

Recent Development:

July 2024: Mars acquired Cerba Healthcares stake in Cerba Vet and ANTAGENE, strengthening its companion animal diagnostics portfolio.

January 2024: Zoetis expanded its Vetscan Imagyst platform with AI-powered urine sediment analysis, enhancing in-clinic diagnostic precision.

May 2024: Zoetis launched the Vetscan OptiCell analyzer, an AI-driven cartridge-based hematology system for advanced in-clinic CBC testing.

February 2025: IDEXX shares rose ~10% following strong demand for companion animal testing products, including a late-stage canine lymphoma Cancer Dx screening test.

Study Period for the Companion Animal Diagnostics Market:

Companion Animal Diagnostics Market

Report Highlights:

Our team of experienced researchers has meticulously gathered and analyzed data to deliver a thorough examination of market dynamics, competitive landscape, and emerging technologies. With a focus on delivering actionable intelligence, this report aims to empower decision-makers with the information needed to make informed choices and stay ahead of the competition. Whether you are a seasoned industry player or a new entrant, our market research report serves as a strategic tool to navigate the complexities of the market, aiding in successful business planning and growth strategies.

Key Chapters of our Companion Animal Diagnostics Market Report includes:

Market Dynamics, Variables, and Industry Analysis:

This chapter of our Companion Animal Diagnostics market report provides an in-depth examination of the factors shaping the industry landscape. This section typically encompasses several key elements to offer a comprehensive understanding of the industry landscape such as market drivers & restraints analysis, market opportunities & trend analysis, market size & growth analysis, competitive analysis, SWOT analysis, business environment tools such as Porter's five forces & PESTEL analysis, Ansoff Matrix analysis, penetration & growth prospect analysis, regulatory framework & reimbursement scenario analysis, impact of macro & micro economic factors analysis such as Covid-19 impact, GDP growth, market inflation, U.S.- China trade war, Russia-Ukraine war impact, and supply chain analysis.

Segment Analysis & Forecast to 2035:

The segment analysis chapter of Companion Animal Diagnostics market report is a critical section that delves into a detailed examination of the market's various segments. Segmentation involves dividing the market into distinct categories based on certain criteria to better understand and address the diverse needs of consumers. This chapter typically follows the introduction and provides a more granular view of the market, offering valuable insights for businesses and stakeholders. The components of the chapter lude segment definitions to understand the inclusions and exclusions of the study, assumptions, market size estimates and growth trend analysis of each segment, qualitative analysis of the segment, technological advancements, market penetration rate, market adoption rate, market share examination by each segment, segment growth drivers and restraint barriers, consumer behaviour and challenge analysis.

Regional Market Analysis & Forecast to 2035:

The chapter in Companion Animal Diagnostics market research report is a pivotal section that examines and predicts the market dynamics and trends specific to different geographical regions. This chapter is crucial for businesses and stakeholders seeking a comprehensive understanding of how the market behaves across various locations, enabling them to tailor strategies and make informed decisions based on regional variations. The regional analysis chapter of our Companion Animal Diagnostics market report is classified into regions & country-level. The chapter consists of North America (U.S., Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Sweden, Denmark, Norway, Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, Thailand, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Colombia, Rest of Latin America), Middle East & Africa (South Africa, Saudi Arabia, UAE, Kuwait, Rest of Middle East & Africa).

Companion Animal Diagnostics Market

Competitive Analysis & Company Profiles:

This section of a Companion Animal Diagnostics market report is a crucial segment that provides a comprehensive overview of the competitive landscape within the market. This section is vital for businesses, investors, and stakeholders seeking insights into key players, their market positioning, strengths, weaknesses, strategies, and potential impacts on the overall market dynamics. The chapter includes research methodology used to analyse the market competition, list of key players operating in the market, detailed company profile section which includes company overview, business verticals, financial performance, product/services benchmarking, geographical presence, and strategic initiatives.

Key Players Operating in the Companion Animal Diagnostics Market are as follows:

• IDEXX Laboratories
• ESAOTE S.p.A
• Agfa-Gevaert Group
• Canon Medical Systems
• Siemens Healthineers
• FUJIFILM Holdings
• GE Healthcare
• Carestream Health
• Heska Corporation
• Hallmarq Veterinary Imaging
• Mindray Medical
• Konica Minolta
• Samsung Electronics
• IMV Imaging
• E.I. Medical Imaging
• SEDECAL
• Draminski S.A.
• Clarius Mobile Health
• Reproscan
• Sonoscape

Companion Animal Diagnostics Market

Report Scope:

Quintile Reports has segmented the Companion Animal Diagnostics market into the following segments:

Based on Product Type, the Companion Animal Diagnostics market is segmented into:

• Equipment
• Accessories/Consumables
• Software

Based on Imaging & Modality, the Companion Animal Diagnostics market is segmented into:

• X-ray
• Ultrasound
• MRI
• CT Scan
• Respiratory Imaging
• Video Endoscopy
• Fixed
• Portable

Based on Animal Type, the Companion Animal Diagnostics market is segmented into:

• Dogs
• Cats
• Horses
• Others

Based on Application, the Companion Animal Diagnostics market is segmented into:

• Orthopedics and Traumatology
• Oncology
• Cardiology
• Neurology
• Respiratory
• Dental Applications
• Others

Based on End User, the Companion Animal Diagnostics market is segmented into:

• Veterinary Hospitals and Clinics
• Specialty Imaging Centers
• Others

Report Scope	Details
Report Version	2026
Growth Rate	CAGR of 10.05 from 2026 to 2035
Base year	2025
Actual estimates/Historical data	2017 - 2024
Forecast period	2026 - 2035
Quantitative units	Revenue in USD million/billion & CAGR from 2026 to 2035
Country scope	North America (U.S., Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Sweden, Denmark, Norway, Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, Thailand, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Colombia, Rest of Latin America), Middle East & Africa (South Africa, Saudi Arabia, UAE, Kuwait, Rest of Middle East & Africa).
The Segment covered by Product Type	Equipment Accessories/Consumables Software
The Segment covered by Imaging & Modality	X-ray Ultrasound MRI CT Scan Respiratory Imaging Video Endoscopy Fixed Portable
Companies covered	IDEXX Laboratories ESAOTE S.p.A Agfa-Gevaert Group Canon Medical Systems Siemens Healthineers FUJIFILM Holdings GE Healthcare Carestream Health Heska Corporation Hallmarq Veterinary Imaging Mindray Medical Konica Minolta Samsung Electronics IMV Imaging E.I. Medical Imaging SEDECAL Draminski S.A. Clarius Mobile Health Reproscan Sonoscape
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Free customization scope (equivalent to 5 analyst working days)	If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of the customization

Key Reasons to Acquire the Companion Animal Diagnostics Market Research Report:

• This report offers a comprehensive analysis of the Companion Animal Diagnostics market from 2017 to 2035, including market segments, current trends, estimations, and dynamics
• It also provides information on key drivers, restraints, and opportunities
• Porter's five forces analysis is used to assess the potency of buyers and suppliers, helping stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network
• The report includes an in-depth analysis of the Companion Animal Diagnostics market segmentation to identify prevailing market opportunities
• Major countries in each region are mapped according to their revenue contribution to the global market
• Market player positioning is also analyzed to facilitate benchmarking and provide a clear understanding of the present position of the market players
• The report includes an analysis of the regional and global Companion Animal Diagnostics market trends, key players, market segments, application areas, and market growth strategies

Companion Animal Diagnostics Market

Available Customizations:

With the given market data, Quintile Reports offers customizations according to the company's specific needs. The following customization options are available for the report:

• You may ask for a global, regional, or country-specific report.
• You may ask if there are any particular types, applications, or products on which you would like to focus.
• You may ask for specific competitors/players to be profiled.

Companion Animal Diagnostics Market Report

Statistics for the 2025 Companion Animal Diagnostics market share, size, and revenue growth rate were created by Quintile Report™. Companion Animal Diagnostics analysis includes a market forecast outlook for 2035 and a historical overview. Get a free PDF sample of this market analysis, please get in touch with our principal analyst at sales@quintilereports.com